Caxton Associates »

Terns Pharmaceuticals shares owned by Caxton Associates

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Caxton Associates from 13F filings

Historical chart of Caxton Associates investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Caxton Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Caxton Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $114k 15k 7.51

More positions owned by Caxton Associates

Tesla Motors (TSLA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Intel Corporation (INTC)
Kellogg Company Put Option (K)
Ishares Msci Mexico Etf (EWW)
Uranium Energy (UEC)
Ishares Msci Brazil Etf (EWZ)
Cameco Corporation (CCJ)
Netflix (NFLX)
Frontier Communications Pare (FYBR)
Kraneshares Trust Csi Chi Internet (KWEB)
Sandisk Corp Put Option (SNDK)

View all positions for Caxton Associates

Top funds holding Terns Pharmaceuticals

Soleus Capital Management
OrbiMed Advisors
Deep Track Capital
Morgan Stanley
Vivo Capital
Commodore Capital
BlackRock
Vanguard Group
Adage Capital Partners GP
Candriam Luxembourg S.C.A.
Acorn Capital Advisors
Schonfeld Strategic Advisors
Geode Capital Management
Citadel Advisors
State Street Corporation

View all funds holding Terns Pharmaceuticals